Abstract：Objective To analyze the multi-drug resistance of the pathogenic bacteria during the microbiological test in our hospital in 2014-2017.Methods A total of 12 306 specimen delivered from 2014 to 2017 in our hospital were selected.The Bio Mérieux VITE2-Compact drug sensitivity analyzer and the microbiological identification instrument were used to take the drug sensitivity test and identification.The multi-drug resistance of the microbiological strains taken in 2014-2017 were evaluated.Results For 12 306 specimen,there were 2000 samples of pathogenic bacteria;the positive detection rate of pathogenic bacteria was 16.3%of which the top three samples included 412 blood specimen (26.9%),280 secretion specimen (17.5%)and 304 sputum specimen (17.0%).There were 403 samples of multi-drug resistant pathogenic bacteria included 136 strains(33.7%)in the respiratory medicine department,120 strains(29.8%)in the cardio-thoracic surgery department,30 strains(7.4%)in the orthopedic surgery department,43 stains(10.7%)in the oncology department,40 strains(9.9%)in the orthopedic surgery department and 23 strains(5.7%)in the burns department and 11 strains(2.8%)in the gastroenterology department.According to the drug resistance analysis of the pathogenic bacteria,the Acinetobacter baumanmii of gram-negative bacteria had the highest drug resistance,followed by Enterobacter cloacae and Escherichia coli.The gram-positive bacteria of Staphylococcus epidermidis and Staphylococcus aureus had the highest drug resistance.Conclusion During the microbiological test in 2014-2017,the gram-negative bacteria have the highest multi-drug resistance.The control and prevention of the nosocomial infection and the reasonable application of the anti-bacterial agents are beneficial to improve the medical treatment quality and reduce the drug resistance of the pathogenic bacteria.
潘桂仪. 2014～2017年我院微生物检验中的多重耐药情况分析[J]. 中国当代医药, 2018, 25(9): 123-125.
PAN Gui-Yi. Analyze of the multi-drug resistance of the pathogenic bacteria during the microbiological test in our hospital in 2014-2017. 中国当代医药, 2018, 25(9): 123-125.
京公网安备 11010502046607号